Singh, A.; Pogorelić, Z.; Agrawal, A.; Muñoz, C.M.L.; Kainth, D.; Verma, A.; Jindal, B.; Agarwala, S.; Anand, S.
Utility of Ischemia-Modified Albumin as a Biomarker for Acute Appendicitis: A Systematic Review and Meta-Analysis. J. Clin. Med. 2023, 12, 5486.
https://doi.org/10.3390/jcm12175486
AMA Style
Singh A, Pogorelić Z, Agrawal A, Muñoz CML, Kainth D, Verma A, Jindal B, Agarwala S, Anand S.
Utility of Ischemia-Modified Albumin as a Biomarker for Acute Appendicitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2023; 12(17):5486.
https://doi.org/10.3390/jcm12175486
Chicago/Turabian Style
Singh, Apoorv, Zenon Pogorelić, Aniket Agrawal, Carlos Martin Llorente Muñoz, Deepika Kainth, Ajay Verma, Bibekanand Jindal, Sandeep Agarwala, and Sachit Anand.
2023. "Utility of Ischemia-Modified Albumin as a Biomarker for Acute Appendicitis: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 12, no. 17: 5486.
https://doi.org/10.3390/jcm12175486
APA Style
Singh, A., Pogorelić, Z., Agrawal, A., Muñoz, C. M. L., Kainth, D., Verma, A., Jindal, B., Agarwala, S., & Anand, S.
(2023). Utility of Ischemia-Modified Albumin as a Biomarker for Acute Appendicitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 12(17), 5486.
https://doi.org/10.3390/jcm12175486